Drugs for benign prostatic hypertrophy

Aust Prescr. 2018 Oct;41(5):150-153. doi: 10.18773/austprescr.2018.045. Epub 2018 Oct 1.


Benign prostatic hyperplasia is a common condition. It can cause problems with urine storage and voiding, and the severity of symptoms may be unrelated to the size of the prostate

When drug treatment is required, benign prostatic hyperplasia can be managed with monotherapy or combination therapy. Most patients are managed with selective alpha blockers

Patients with larger prostate volumes may benefit from a 5-alpha-reductase inhibitor, usually in combination with an alpha blocker

Keywords: 5-alpha-reductase inhibitors; alpha blockers; benign prostatic hyperplasia.

Publication types

  • Review